CoChat

Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation

Open access
Magen, I, Avraham, Y, Ackerman, Z, Vorobiev, L, Mechoulam, R, Berry, EM · 2010 · British Journal of Pharmacology
Cited by 119

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Background and purpose: We aimed to demonstrate the involvement of 5‐HT 1A receptors in the therapeutic effect of cannabidiol, a non‐psychoactive constituent of Cannabis sativa, in a model of hepatic encephalopathy induced by bile‐duct ligation (BDL) in mice. Experimental approach: Cannabidiol (5 mg·kg−1; i.p.) was administered over 4 weeks to BDL mice. Cognition and locomotion were evaluated using the eight‐arm maze and the open field tests respectively. Hippocampi were analysed by RT‐PCR for expression of the genes for tumour necrosis factor‐α receptor 1, brain‐derived neurotrophic factor (BDNF) and 5‐HT 1A receptor. N‐(2‐(4‐(2‐methoxy‐phenyl)‐1‐piperazin‐1‐yl)ethyl)‐N‐(2‐pyridyl) cyclohexanecarboxamide (WAY‐100635), a 5‐HT 1A receptor antagonist (0.5 mg·kg−1), was co‐administered with cannabidiol. Liver function was evaluated by measuring plasma liver enzymes and bilirubin. Key results: Cannabidiol improved cognition and locomotion, which were impaired by BDL, and restored hippocampal expression of the tumour necrosis factor‐α receptor 1 and the BDNF genes, which increased and decreased, respectively, following BDL. It did not affect reduced 5‐HT 1A expression in BDL mice. All the effects of cannabidiol, except for that on BDNF expression, were blocked by WAY‐100635, indicating 5‐HT 1A receptor involvement in cannabidiol's effects. Cannabidiol did not affect the impaired liver function in BDL. Conclusions and implications: The behavioural outcomes of BDL result from both 5‐HT 1A receptor down‐regulation and neuroinflammation. Cannabidiol reverses these effects through a combination of anti‐inflammatory activity and activation of this receptor, leading to improvement of the neurological deficits without affecting 5‐HT 1A receptor expression or liver function. BDNF up‐regulation by cannabidiol does not seem to account for the cognitive improvement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00589.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 119

Metadata

Authors
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2010-02
Volume
159
Issue
4
Pages
950-957
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1562709508
Cited by
119
References
16
FWCI
5.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00589.x
The paper
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010). Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00589.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.